Hepatitis A, B and C in New York City: 2024 Annual Report

Hepatitis A, B and C in New York City: 2024 Surveillance Annual Report provides the latest surveillance data on viral hepatitis in New York City. Use this data to inform hepatitis intervention planning, advocate or seek grants for funding, and educate providers and patients.

Read the 2024 Annual Report (PDF)

Hepatitis B Highlights

• The number of people newly reported with chronic hepatitis B in NYC increased 15%, due in part to updated screening recommendations by the CDC.
• Among the 8,029 people newly reported with chronic hepatitis B:
  • 61% male
  • 27% ages 30 to 39
  • 47% Asian or Pacific Islander
  • 32% Black
• Queens and Brooklyn have the highest rates of people newly reported with chronic hepatitis B.
• The rate of death with hepatitis B was higher among Asian and Pacific Islander people, a trend that has persisted over the last nine years.

Hepatitis C Highlights

• The number of people newly reported with chronic hepatitis C in NYC decreased 4%, reaching its lowest level in a decade.
• Of all people reported with hepatitis C since 2014, 72% were cured or cleared of the virus as of 2024.
• Among the 2,188 people newly reported with chronic hepatitis C:
  • 63% male
  • 42% ages 30 to 49
  • 31% Black
  • 29% white
  • 28% Latino/a
• The Bronx and Brooklyn have the highest rates of people reported with acute hepatitis C and people newly reported with chronic hepatitis C.
• Male-to-male sexual contact, HIV infection, and injection drug use were the most frequently reported risk factors among a group of people newly reported with acute or chronic hepatitis C and interviewed by the NYC Health Department.